158 related articles for article (PubMed ID: 34181629)
1. Comparison chart: Some drugs for HFrEF.
Med Lett Drugs Ther; 2021 Jun; 63(1626):e1-e14. PubMed ID: 34181629
[No Abstract] [Full Text] [Related]
2. Comparison table: Some drugs for HFrEF.
Med Lett Drugs Ther; 2021 Mar; 63(1619):e1-e13. PubMed ID: 33755656
[No Abstract] [Full Text] [Related]
3. Drugs for chronic heart failure.
Med Lett Drugs Ther; 2021 Jun; 63(1626):89-96. PubMed ID: 34181628
[No Abstract] [Full Text] [Related]
4. Expanded table: Some drugs for HFrEF.
Med Lett Drugs Ther; 2019 Apr; 61(1569):e57-e62. PubMed ID: 31169798
[No Abstract] [Full Text] [Related]
5. Drugs for chronic heart failure.
Med Lett Drugs Ther; 2019 Apr; 61(1569):49-54. PubMed ID: 31169796
[No Abstract] [Full Text] [Related]
6. Drugs for hypertension.
Med Lett Drugs Ther; 2020 May; 62(1598):73-80. PubMed ID: 32555118
[No Abstract] [Full Text] [Related]
7. Drugs for hypertension.
Med Lett Drugs Ther; 2024 May; 66(1703):81-88. PubMed ID: 38771738
[No Abstract] [Full Text] [Related]
8. Vericiguat (Verquvo) for heart failure.
Med Lett Drugs Ther; 2021 Mar; 63(1619):36-37. PubMed ID: 33755653
[No Abstract] [Full Text] [Related]
9. Cost-effectiveness of sacubitril/valsartan in the treatment of heart failure with reduced ejection fraction.
McMurray JJV; Trueman D; Hancock E; Cowie MR; Briggs A; Taylor M; Mumby-Croft J; Woodcock F; Lacey M; Haroun R; Deschaseaux C
Heart; 2018 Jun; 104(12):1006-1013. PubMed ID: 29269379
[TBL] [Abstract][Full Text] [Related]
10. Update of treatment of heart failure with reduction of left ventricular ejection fraction.
Aronow WS
Arch Med Sci Atheroscler Dis; 2016; 1(1):e106-e116. PubMed ID: 28905031
[TBL] [Abstract][Full Text] [Related]
11. New drugs for the treatment of chronic heart failure with a reduced ejection fraction: What the future may hold.
Sciatti E; Dallapellegrina L; Metra M; Lombardi CM
J Cardiovasc Med (Hagerstown); 2019 Oct; 20(10):650-659. PubMed ID: 31397687
[TBL] [Abstract][Full Text] [Related]
12. A Review of New Pharmacologic Treatments for Patients With Chronic Heart Failure With Reduced Ejection Fraction.
Nguyen E; Weeda ER; White CM
J Clin Pharmacol; 2016 Aug; 56(8):936-47. PubMed ID: 26626162
[TBL] [Abstract][Full Text] [Related]
13. MY APPROACH to the patient with heart failure and improved ejection fraction
Cohn JN
Trends Cardiovasc Med; 2018 Feb; 28(2):153. PubMed ID: 29032935
[No Abstract] [Full Text] [Related]
14. Pharmacologic Therapy for Heart Failure With Reduced Ejection Fraction: Closing the Gap Between Clinical Guidelines and Practice.
Biglane JB; Becnel MF; Ventura HO; Krim SR
Prog Cardiovasc Dis; 2017; 60(2):187-197. PubMed ID: 28847619
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
[TBL] [Abstract][Full Text] [Related]
16. Influence of Ejection Fraction on Outcomes and Efficacy of Sacubitril/Valsartan (LCZ696) in Heart Failure with Reduced Ejection Fraction: The Prospective Comparison of ARNI with ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure (PARADIGM-HF) Trial.
Solomon SD; Claggett B; Desai AS; Packer M; Zile M; Swedberg K; Rouleau JL; Shi VC; Starling RC; Kozan Ö; Dukat A; Lefkowitz MP; McMurray JJ
Circ Heart Fail; 2016 Mar; 9(3):e002744. PubMed ID: 26915374
[TBL] [Abstract][Full Text] [Related]
17. Switching from ramipril to sacubitril/valsartan favorably alters electrocardiographic indices of ventricular repolarization in heart failure with reduced ejection fraction.
Okutucu S; Sabanoglu C; Yetis Sayin B; Aksoy H; Bursa N; Oto A
Acta Cardiol; 2020 Feb; 75(1):20-25. PubMed ID: 30513267
[No Abstract] [Full Text] [Related]
18. The reverse remodeling response to sacubitril/valsartan therapy in heart failure with reduced ejection fraction.
Martens P; Beliën H; Dupont M; Vandervoort P; Mullens W
Cardiovasc Ther; 2018 Aug; 36(4):e12435. PubMed ID: 29771478
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and Safety of Ivabradine in Japanese Patients With Chronic Heart Failure - J-SHIFT Study.
Tsutsui H; Momomura SI; Yamashina A; Shimokawa H; Kihara Y; Saito Y; Hagiwara N; Ito H; Yano M; Yamamoto K; Ako J; Inomata T; Sakata Y; Tanaka T; Kawasaki Y;
Circ J; 2019 Sep; 83(10):2049-2060. PubMed ID: 31391387
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
